Ovoca Bio | OVG - Interest Expense On Debt


Ovoca Bio reported EUR7K in Interest Expense on Debt for its fiscal semester ending in June of 2022.





Interest Expense On Debt Change Date
Akebia Therapeutics 362.52M 357.69M Mar/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
ALKERMES USD 20.89M 8.62M Mar/2026
Avita Medical AUD 1.25M 100K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Ionis Pharmaceuticals USD 17M 1000K Mar/2026
IQVIA Holdings USD 192M 1000K Mar/2026
Moderna USD 11.49B 36B Mar/2026
Organon & Co USD 128M 3M Sep/2025
Ovoca Bio EUR 7K 6K Jun/2022
Revvity USD 24.72M 1.2M Mar/2026
Tectonic Therapeutic USD 246.58M 246.56M Mar/2026
Viatris USD 120.1M 500K Mar/2026
Xeris Pharmaceuticals USD 7.15M 115K Dec/2025